Trials / Conditions / Complicated Intra-abdominal Infection

Complicated Intra-abdominal Infection

18 registered clinical trials studyying Complicated Intra-abdominal Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea NCT05733104	Pfizer	—
Completed	P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available T NCT05905055	Meiji Seika Pharma Co., Ltd.	Phase 3
Recruiting	EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Inf NCT05148702	Sarah Cockayne	Phase 3
Completed	Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal NCT04927312	Pfizer	Phase 3
Completed	A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (M NCT03329092	Pfizer	Phase 3
Completed	MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infect NCT03217136	Merck Sharp & Dohme LLC	Phase 2
Completed	Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Int NCT03293485	Merck Sharp & Dohme LLC	Phase 3
Completed	Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Com NCT02739997	Merck Sharp & Dohme LLC	Phase 3
Completed	Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd NCT01726023	Pfizer	Phase 3
Completed	Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens NCT01644643	Pfizer	Phase 3
Completed	Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra- NCT01499290	Pfizer	Phase 3
Completed	Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraa NCT01445678	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 3
Completed	Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections NCT01265784	Tetraphase Pharmaceuticals, Inc	Phase 2
Withdrawn	Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired NCT01602874	Pfizer	Phase 3
Withdrawn	Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired NCT00914888	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 3
Completed	Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Int NCT01147640	Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	Phase 2
Completed	Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal NCT00929643	Wyeth is now a wholly owned subsidiary of Pfizer	—
Completed	A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infection NCT00157898	Merck Sharp & Dohme LLC	Phase 4